Eyewire News

Featured Story

08.10.2026

Oculis to Acquire Global Rights to Privosegtor from Accure Therapeutics

Oculis and Accure Therapeutics have entered into an asset purchase agreement under which Oculis will acquire Accure’s worldwide development and commercial rights to Privosegtor (ACT-01), a neuroprotective candidate currently in registrational development for optic neuritis. The transaction will terminate Oculis’ existing license agreement with Accure, including associated milestone and royalty obligations for successful indications.

Read Story

Latest News Stories

08.10.2026

PracticeAmerica Launches Physician-to-Physician Marketplace for Independent Practice Transitions

08.10.2026

Nicox Licensee Submits Application for Glaucoma Candidate NCX 470 in China

Contact Lens Institute Taps Olympic Medalist Nancy Kerrigan for Contact Lens Care Campaign image

08.10.2026

Contact Lens Institute Taps Olympic Medalist Nancy Kerrigan for Contact Lens Care Campaign

WaveFront Dynamics Expands Scleral Lens Options Through Bausch + Lomb, WAVE Eye Care Integrations image

08.10.2026

WaveFront Dynamics Expands Scleral Lens Options Through Bausch + Lomb, WAVE Eye Care Integrations

08.07.2026

UK Study Finds Ophthalmic Clinical Letters Increasingly Difficult for Patients to Read

Harrow to Acquire Nasal Dry Eye Disease Treatment Tyrvaya from Viatris image

08.07.2026

Harrow to Acquire Nasal Dry Eye Disease Treatment Tyrvaya from Viatris

ForSight Robotics Reports 26 Fully Robotic-Assisted Cataract Surgeries in First-in-Human Study image

08.07.2026

ForSight Robotics Reports 26 Fully Robotic-Assisted Cataract Surgeries in First-in-Human Study

Norlase Expands European Footprint image

08.06.2026

Norlase Expands European Footprint with Direct Sales Model in Germany

Bascom Palmer Eye Institute Ranked Nation’s No. 1 in Ophthalmology image

08.06.2026

Bascom Palmer Eye Institute Ranked No. 1 in Ophthalmology in United States

Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals image

08.06.2026

Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals

Staar Surgical Appoints Warren Foust as President and CEO image

08.05.2026

Staar Surgical Appoints Warren Foust as President and CEO

08.05.2026

Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Trial of Oral NPDR Therapy

08.04.2026

University of Iowa Research Underpins First-in-Human UK Study of Gene Therapy Targeting Rare IRD

08.04.2026

Swedish Study Finds Small Absolute Risk of NAION Among GLP-1 Receptor Agonist Users

Opus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease image

08.04.2026

Opus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease

$MDConsult AI Launches Pre-Consultation Platform for Cataract and Refractive Practices image$

08.03.2026

MDConsult AI Launches Pre-Consultation Platform for Cataract and Refractive Practices

Biocon Launches Aflibercept Biosimilar Yesafili in the US image

08.03.2026

Biocon Launches Aflibercept Biosimilar Yesafili in the US

08.03.2026

Oculis Receives FDA Pre-IND Feedback Supporting Privosegtor Development in Acute MS Relapses

07.31.2026

UK College of Optometrists Seeks Feedback on Major Update to Professional Practice Guidance

View More